Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability

Author： Brandl Michael   Wu Xiaoyang   Holper Marites   Hong Lei   Jia Zhongjiang   Birudaraj Raj   Reddy Micaela   Alfredson Tom   Tran Tony   Larrabee Susan   Hadig Xu   Sarma Keshab   Washington Carla   Hill George   Smith David  

Publisher： Informa Healthcare

ISSN： 0363-9045

Source： Drug Development and Industrial Pharmacy, Vol.34, Iss.7, 2008-07, pp. : 683-691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies to Increase the Oral Bioavailability of Nucleoside Analogs

By  

Current Medicinal Chemistry, Vol. 16, Iss. 11, 2009-04 ,pp. : 1391-1399

Bentham Science Publishers

Access to resources Recommend Favorite

A Prodrug Approach to Improve the Physico-Chemical Properties and Decrease the Genotoxicity of Nitro Compounds

By  

Current Pharmaceutical Design, Vol. 17, Iss. 32, 2011-11 ,pp. : 3515-3526

Bentham Science Publishers

Access to resources Recommend Favorite

PepT1, ASBT-Linked Prodrug Strategy to Improve Oral Bioavailability and Tissue Targeting Distribution

By  

Current Drug Metabolism, Vol. 16, Iss. 1, 2015-01 ,pp. : 71-83

Bentham Science Publishers

Access to resources Recommend Favorite

R 7128, a prodrug of a cytidine nucleoside analogue inhibitor of HCV RNA polymerase, appears to be active in chronic HCV genotype 1 infections

By  

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans

By Hurst Susan   Loi Cho-Ming   Brodfuehrer Joanne   El-Kattan Ayman  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 4, 2007-08 ,pp. : 469-489

Informa Healthcare

Access to resources Recommend Favorite